Page last updated: 2024-10-23

azathioprine and Immunoblastic Large-Cell Lymphoma

azathioprine has been researched along with Immunoblastic Large-Cell Lymphoma in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagenah, GC1
Wündisch, T1
Eckstein, E1
Zimmermann, S1
Holst, F1
Grimm, W1
Neubauer, A1
Lohoff, M1

Other Studies

1 other study available for azathioprine and Immunoblastic Large-Cell Lymphoma

ArticleYear
[Sepsis-like disease in an immunocompromised patient with a travel history to Mallorca].
    Der Internist, 2007, Volume: 48, Issue:7

    Topics: Adult; Animals; Azathioprine; Biopsy; Bone Marrow; Colectomy; Colitis, Ulcerative; Colon; Colonic Ne

2007